Willems Margo, Devriendt Céline, Olsen Catharina, Caljon Ben, Janssen Toon, Gies Inge, Vloeberghs Veerle, Tournaye Herman, Van Saen Dorien, Goossens Ellen
Biology of the Testis (BITE) Laboratory, Department of Reproduction, Genetics and Regenerative Medicine, Vrije Universiteit Brussel (VUB), Laarbeeklaan 103, 1090 Brussels, Belgium.
Brussels Interuniversity Genomics High Throughput Core (BRIGHTcore) Platform, Universitair Ziekenhuis Brussel (UZ Brussel), Vrije Universiteit Brussel (VUB), Laarbeeklaan 101, 1090 Brussels, Belgium.
Life (Basel). 2023 Feb 23;13(3):616. doi: 10.3390/life13030616.
About half of testicular sperm extraction (TESE) procedures in men with non-obstructive azoospermia (NOA), including men with Klinefelter syndrome (KS), are unsuccessful. To avoid unnecessary invasive surgery, biomarkers for spermatozoa were studied. In addition, markers for spermatogonia in testis tissue were explored. This study aimed to find biomarkers in the semen and/or urine of NOA patients to predict the presence of spermatogonia in the testis. Differentially expressed miRNAs were identified (1) between samples from patients with and without a positive TESE procedure as well as (2) between TESE-negative patients with and without spermatogonia. A total of thirteen upregulated miRNAs (ten in seminal plasma and three in urine) were found in the TESE-negative/spermatogonia-positive group compared to the TESE-negative/spermatogonia-negative group. These miRNAs could be potential biomarkers for spermatogonia; however, more research is necessary to validate their predictive power.
在患有非梗阻性无精子症(NOA)的男性中,包括患有克兰费尔特综合征(KS)的男性,约一半的睾丸精子提取(TESE)手术不成功。为避免不必要的侵入性手术,对精子生物标志物进行了研究。此外,还探索了睾丸组织中生精细胞的标志物。本研究旨在寻找NOA患者精液和/或尿液中的生物标志物,以预测睾丸中生精细胞的存在。确定了差异表达的miRNA:(1)在TESE手术阳性和阴性患者的样本之间,以及(2)在TESE阴性且有或无生精细胞的患者之间。与TESE阴性/无生精细胞组相比,在TESE阴性/有生精细胞组中总共发现了13种上调的miRNA(10种在精浆中,3种在尿液中)。这些miRNA可能是生精细胞的潜在生物标志物;然而,需要更多研究来验证它们的预测能力。